Suggestions
MSc Belen Fraile
Chief Data & Digital Officer (CDO) and Head of Innovation, US Oncology. Member of the US Oncology Executive Committee.
Dr. Belen Fraile is a healthcare executive with over 15 years of experience in clinical practice, hospital administration, healthcare policy, academia, and pharmaceuticals.
Currently serving as the Chief Digital Officer and Head of Innovation at Novartis Oncology, Dr. Fraile leads the data and digital transformation of the US division, focusing on clinical innovation, value, and enhancing the patient journey through data, digital, and analytics.
Passionate about healthcare innovation, biotechnology, data and digital solutions, health policy, and transforming health systems for better patient outcomes.
Her expertise lies in data, digital, and analytics in the healthcare and pharmaceutical industry, including omnichannel execution, analytics enablement for business and clinical teams, and implementing digital tools in healthcare settings.
Specializes in health policy, value-based care, health reform implementation, healthcare delivery models, payment models, and value measurement in healthcare.
Recipient of a Fulbright Scholarship and holds a MSc in Health Care Policy and Management from Harvard School of Public Health and a MD from Complutense University of Madrid.
Board Certified in Obstetrics and Gynecology with educational background from top institutions like MIT Sloan School of Management and Harvard T.H. Chan School of Public Health.